🔎 Trials Near Me

Akèy › Kolestewòl › Washington

Etid klinik pou Kolestewòl nan Washington, DC

7 etid pou Kolestewòl ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia

Ap rekriteFaz 3
  • Research Site, Beltsville · 12 mi lwen
Laj 18 a 130 · Tout sèks · Mizajou Oct 5, 2026 · NCT07619118

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Ap rekriteFaz 4
  • Washington Vascular Specialists - ClinRe 001-136, Takoma Park · 6 mi lwen
  • Jadestone Clinical Research, LLC, Silver Spring · 7 mi lwen
  • Capitol Cardiology Associates PA, Lanham · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06909565

Causes and Natural History of Dyslipidemias

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 2 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT00353782

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

Ap rekriteFaz 3
  • Research Site, Beltsville · 12 mi lwen
  • Research Site, Bowie · 17 mi lwen
Laj 18 a 130 · Tout sèks · Mizajou Sep 10, 2026 · NCT07619131

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

Ap rekriteFaz 2
  • Capitol Cardiology Associates, Lanham · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Jul 30, 2026 · NCT07610278

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Ap rekriteFaz 3
  • Childrens National Hospital, Washington D.C.
Laj 2 a 11 · Tout sèks · Mizajou Jul 24, 2026 · NCT06597006

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Ap rekriteFaz 3
  • Children's National Hospital, Washington D.C.
  • Childrens National Hospital, Washington D.C.
Laj 6 a 11 · Tout sèks · Mizajou May 15, 2026 · NCT06597019

Etid Kolestewòl nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.